These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 36863691)

  • 1. Nanomedicine is more than a supporting role in rheumatoid arthritis therapy.
    Han Y; Huang S
    J Control Release; 2023 Apr; 356():142-161. PubMed ID: 36863691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology-empowered combination therapy for rheumatoid arthritis: principles, strategies, and challenges.
    Ren S; Xu Y; Dong X; Mu Q; Chen X; Yu Y; Su G
    J Nanobiotechnology; 2024 Jul; 22(1):431. PubMed ID: 39034407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano - Based Therapeutic Strategies in Management of Rheumatoid Arthritis.
    Nautiyal G; Sharma SK; Kaushik D; Pandey P
    Recent Pat Nanotechnol; 2024; 18(4):433-456. PubMed ID: 37904559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine - advantages for their use in rheumatoid arthritis theranostics.
    Xiao S; Tang Y; Lv Z; Lin Y; Chen L
    J Control Release; 2019 Dec; 316():302-316. PubMed ID: 31715278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secreted Protein Acidic and Rich in Cysteine Mediated Biomimetic Delivery of Methotrexate by Albumin-Based Nanomedicines for Rheumatoid Arthritis Therapy.
    Liu L; Hu F; Wang H; Wu X; Eltahan AS; Stanford S; Bottini N; Xiao H; Bottini M; Guo W; Liang XJ
    ACS Nano; 2019 May; 13(5):5036-5048. PubMed ID: 30978282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nanometer preparation of traditional Chinese medicine for rheumatoid arthritis].
    Wang HM; Wang M
    Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(18):3908-3916. PubMed ID: 31872724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicines for chronic non-infectious arthritis: the clinician's perspective.
    Rubinstein I; Weinberg GL
    Nanomedicine; 2012 Sep; 8 Suppl 1():S77-82. PubMed ID: 22640912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicines for chronic non-infectious arthritis: the clinician's perspective.
    Rubinstein I; Weinberg GL
    Maturitas; 2012 Sep; 73(1):68-73. PubMed ID: 22264497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in therapeutic strategies and biomimetic nanomedicines for rheumatoid arthritis treatment.
    Li C; Zheng X; Hu M; Jia M; Jin R; Nie Y
    Expert Opin Drug Deliv; 2022 Aug; 19(8):883-898. PubMed ID: 35760767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-platform Strategies of Herbal Components for the Management of Rheumatoid Arthritis: A Review on the Battle for Next-Generation Formulations.
    Prabha J; Kumar M; Kumar D; Chopra S; Bhatia A
    Curr Drug Deliv; 2024; 21(8):1082-1105. PubMed ID: 37622715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicines for the delivery of glucocorticoids and nucleic acids as potential alternatives in the treatment of rheumatoid arthritis.
    Yu Z; Reynaud F; Lorscheider M; Tsapis N; Fattal E
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1630. PubMed ID: 32202079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Move to Nano-Arthrology: Targeted Stimuli-Responsive Nanomedicines Combat Adaptive Treatment Tolerance (ATT) of Rheumatoid Arthritis.
    Liu L; Guo W; Liang XJ
    Biotechnol J; 2019 Jan; 14(1):e1800024. PubMed ID: 30221835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine targeted anti-inflammatory therapy to deal with the 'crux' of rheumatoid arthritis.
    An M; Zhang J; Zhang X; Zhao Y; Liu Y
    J Drug Target; 2024 Apr; 32(4):381-392. PubMed ID: 38321981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicine for the Treatment of Rheumatoid Arthritis.
    Jeong M; Park JH
    Mol Pharm; 2021 Feb; 18(2):539-549. PubMed ID: 32502346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicines for improved targetability to inflamed synovium for treatment of rheumatoid arthritis: Multi-functionalization as an emerging strategy to optimize therapeutic efficacy.
    Fang G; Zhang Q; Pang Y; Thu HE; Hussain Z
    J Control Release; 2019 Jun; 303():181-208. PubMed ID: 31015032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposome-Based Nanomedicine Therapeutics for Rheumatoid Arthritis.
    Rahman M; Beg S; Anwar F; Kumar V; Ubale R; Addo RT; Ali R; Akhter S
    Crit Rev Ther Drug Carrier Syst; 2017; 34(4):283-316. PubMed ID: 29199587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted drug-delivery systems in the treatment of rheumatoid arthritis: recent advancement and clinical status.
    Gorantla S; Singhvi G; Rapalli VK; Waghule T; Dubey SK; Saha RN
    Ther Deliv; 2020 Apr; 11(4):269-284. PubMed ID: 32434463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent approaches for targeted drug delivery in rheumatoid arthritis diagnosis and treatment.
    Pirmardvand Chegini S; Varshosaz J; Taymouri S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):502-514. PubMed ID: 29661045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in Nanotheranostics for Treat-to-Target of Rheumatoid Arthritis.
    Wang S; Lv J; Meng S; Tang J; Nie L
    Adv Healthc Mater; 2020 Mar; 9(6):e1901541. PubMed ID: 32031759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential therapeutic compounds from traditional Chinese medicine targeting endoplasmic reticulum stress to alleviate rheumatoid arthritis.
    de Seabra Rodrigues Dias IR; Lo HH; Zhang K; Law BYK; Nasim AA; Chung SK; Wong VKW; Liu L
    Pharmacol Res; 2021 Aug; 170():105696. PubMed ID: 34052360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.